These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

237 related articles for article (PubMed ID: 32779023)

  • 41. Molecular markers identify subtypes of stage III colon cancer associated with patient outcomes.
    Sinicrope FA; Shi Q; Smyrk TC; Thibodeau SN; Dienstmann R; Guinney J; Bot BM; Tejpar S; Delorenzi M; Goldberg RM; Mahoney M; Sargent DJ; Alberts SR
    Gastroenterology; 2015 Jan; 148(1):88-99. PubMed ID: 25305506
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Prognostic value of BRAF and KRAS mutation status in stage II and III microsatellite instable colon cancers.
    de Cuba EM; Snaebjornsson P; Heideman DA; van Grieken NC; Bosch LJ; Fijneman RJ; Belt E; Bril H; Stockmann HB; Hooijberg E; Punt CJ; Koopman M; Nagtegaal ID; Coupé VH; Carvalho B; Meijer GA
    Int J Cancer; 2016 Mar; 138(5):1139-45. PubMed ID: 26376292
    [TBL] [Abstract][Full Text] [Related]  

  • 43.
    Charlton ME; Kahl AR; Greenbaum AA; Karlitz JJ; Lin C; Lynch CF; Chen VW
    J Natl Compr Canc Netw; 2017 Dec; 15(12):1484-1493. PubMed ID: 29223986
    [No Abstract]   [Full Text] [Related]  

  • 44. Feasibility of MRI Radiomics for Predicting KRAS Mutation in Rectal Cancer.
    Guo XF; Yang WQ; Yang Q; Yuan ZL; Liu YL; Niu XH; Xu HB
    Curr Med Sci; 2020 Dec; 40(6):1156-1160. PubMed ID: 33428144
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The Impact of KRAS Mutation on the Presentation and Prognosis of Non-Metastatic Colon Cancer: an Analysis from the National Cancer Database.
    Scott A; Goffredo P; Ginader T; Hrabe J; Gribovskaja-Rupp I; Kapadia MR; Weigel RJ; Hassan I
    J Gastrointest Surg; 2020 Jun; 24(6):1402-1410. PubMed ID: 32128676
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Site-specific Differences in Colonic Adenocarcinoma: KRAS Mutations and High Tumor Budding Are More Frequent in Cecal Adenocarcinoma.
    Landau MA; Zhu B; Akwuole FN; Pai RK
    Am J Surg Pathol; 2018 Mar; 42(3):351-358. PubMed ID: 29240583
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Differences of protein expression profiles, KRAS and BRAF mutation, and prognosis in right-sided colon, left-sided colon and rectal cancer.
    Gao XH; Yu GY; Gong HF; Liu LJ; Xu Y; Hao LQ; Liu P; Liu ZH; Bai CG; Zhang W
    Sci Rep; 2017 Aug; 7(1):7882. PubMed ID: 28801584
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Multifunctional imaging signature for V-KI-RAS2 Kirsten rat sarcoma viral oncogene homolog (KRAS) mutations in colorectal cancer.
    Miles KA; Ganeshan B; Rodriguez-Justo M; Goh VJ; Ziauddin Z; Engledow A; Meagher M; Endozo R; Taylor SA; Halligan S; Ell PJ; Groves AM
    J Nucl Med; 2014 Mar; 55(3):386-91. PubMed ID: 24516257
    [TBL] [Abstract][Full Text] [Related]  

  • 49. KRAS mutation and microsatellite instability: two genetic markers of early tumor development that influence the prognosis of colorectal cancer.
    Nash GM; Gimbel M; Cohen AM; Zeng ZS; Ndubuisi MI; Nathanson DR; Ott J; Barany F; Paty PB
    Ann Surg Oncol; 2010 Feb; 17(2):416-24. PubMed ID: 19813061
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Spectral CT-based nomogram for preoperative prediction of perineural invasion in locally advanced gastric cancer: a prospective study.
    Li J; Xu S; Wang Y; Fang M; Ma F; Xu C; Li H
    Eur Radiol; 2023 Jul; 33(7):5172-5183. PubMed ID: 36826503
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Comparative analysis of real-time quantitative PCR-Sanger sequencing method and TaqMan probe method for detection of KRAS/BRAF mutation in colorectal carcinomas].
    Zhang X; Wang Y; Gao N; Wang J
    Zhonghua Bing Li Xue Za Zhi; 2014 Feb; 43(2):77-82. PubMed ID: 24742565
    [TBL] [Abstract][Full Text] [Related]  

  • 52. High Frequency of KRAS Codon 146 and FBXW7 Mutations in Thai Patients with Stage II-III Colon Cancer.
    Korphaisarn K; Pongpaibul A; Roothumnong E; Pongsuktavorn K; Thamlikitkul L; Anekpuritanang T; Poungvarin N; Thongnoppakhun W; Pithukpakorn M
    Asian Pac J Cancer Prev; 2019 Aug; 20(8):2319-2326. PubMed ID: 31450901
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Association study of the let-7 miRNA-complementary site variant in the 3' untranslated region of the KRAS gene in stage III colon cancer (NCCTG N0147 Clinical Trial).
    Sha D; Lee AM; Shi Q; Alberts SR; Sargent DJ; Sinicrope FA; Diasio RB
    Clin Cancer Res; 2014 Jun; 20(12):3319-27. PubMed ID: 24727325
    [TBL] [Abstract][Full Text] [Related]  

  • 54. A Deep Learning Model Based on MRI and Clinical Factors Facilitates Noninvasive Evaluation of KRAS Mutation in Rectal Cancer.
    Liu H; Yin H; Li J; Dong X; Zheng H; Zhang T; Yin Q; Zhang Z; Lu M; Zhang H; Wang D
    J Magn Reson Imaging; 2022 Dec; 56(6):1659-1668. PubMed ID: 35587946
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Computed Tomography-Based Radiomic Features Could Potentially Predict Microsatellite Instability Status in Stage II Colorectal Cancer: A Preliminary Study.
    Fan S; Li X; Cui X; Zheng L; Ren X; Ma W; Ye Z
    Acad Radiol; 2019 Dec; 26(12):1633-1640. PubMed ID: 30929999
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Prognostic role of KRAS and BRAF in stage II and III resected colon cancer: results of the translational study on the PETACC-3, EORTC 40993, SAKK 60-00 trial.
    Roth AD; Tejpar S; Delorenzi M; Yan P; Fiocca R; Klingbiel D; Dietrich D; Biesmans B; Bodoky G; Barone C; Aranda E; Nordlinger B; Cisar L; Labianca R; Cunningham D; Van Cutsem E; Bosman F
    J Clin Oncol; 2010 Jan; 28(3):466-74. PubMed ID: 20008640
    [TBL] [Abstract][Full Text] [Related]  

  • 57. KRAS and BRAF mutational status in colon cancer from Albanian patients.
    Martinetti D; Costanzo R; Kadare S; Alimehmeti M; Colarossi C; Canzonieri V; Berretta M; Memeo L
    Diagn Pathol; 2014 Sep; 9():187. PubMed ID: 25267307
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Relationship between KRAS mutations and dual time point
    Mao W; Zhou J; Zhang H; Qiu L; Tan H; Hu Y; Shi H
    Abdom Radiol (NY); 2019 Jun; 44(6):2059-2066. PubMed ID: 30143816
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Prognostic value of preoperative prognostic nutritional index and its associations with systemic inflammatory response markers in patients with stage III colon cancer.
    Peng J; Zhang R; Zhao Y; Wu X; Chen G; Wan D; Lu Z; Pan Z
    Chin J Cancer; 2017 Dec; 36(1):96. PubMed ID: 29268783
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Neoadjuvant chemotherapy in locally advanced colon cancer. A phase II trial.
    Jakobsen A; Andersen F; Fischer A; Jensen LH; Jørgensen JC; Larsen O; Lindebjerg J; Pløen J; Rafaelsen SR; Vilandt J
    Acta Oncol; 2015 Nov; 54(10):1747-53. PubMed ID: 25920359
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.